4.5 Article

Artemin Stimulates Oncogenicity and Invasiveness of Human Endometrial Carcinoma Cells

Journal

ENDOCRINOLOGY
Volume 151, Issue 3, Pages 909-920

Publisher

ENDOCRINE SOC
DOI: 10.1210/en.2009-0979

Keywords

-

Funding

  1. New Zealand Breast Cancer Research Trust
  2. Foundation of Research Science and Technology
  3. Hundred-Talent Scheme of Chinese Academy of Sciences
  4. National Natural Science Foundation of China [30571030]
  5. National Basic Research Program of China [2007CB914503]
  6. National Key Scientific Program of China [2007CB914801]
  7. NewZealand National Research Centre
  8. Royal Society of New Zealand

Ask authors/readers for more resources

Here, we provide evidence for a functional role of artemin (ARTN) in progression of endometrial carcinoma (EC). Increased ARTN protein expression was observed in EC compared with normal endometrial tissue, and ARTN protein expression in EC was significantly associated with higher tumor grade and invasiveness. Forced expression of ARTN in EC cells significantly increased total cell number as a result of enhanced cell cycle progression and cell survival. In addition, forced expression of ARTN significantly enhanced anchorage-independent growth and invasiveness of EC cells. Moreover, forced expression of ARTN increased tumor size in xenograft models and produced highly proliferative, poorly differentiated, and invasive tumors. The ARTN-stimulated increases in oncogenicity and invasion were mediated by increased expression and activity of AKT1. Small interfering RNA-mediated depletion or antibody inhibition of ARTN significantly reduced oncogenicity and invasion of EC cells. Thus, inhibition of ARTN may be considered as a potential therapeutic strategy to retard progression of EC. (Endocrinology 151: 909-920, 2010)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available